Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
2.
J Biol Chem ; 276(15): 12140-6, 2001 Apr 13.
Article in English | MEDLINE | ID: mdl-11278624

ABSTRACT

Persistent hepatitis C virus (HCV) infection often progresses to chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Numerous viruses have been reported to escape from apoptotic mechanism to maintain persistent infection. In the present study, we characterized the effect of HCV proteins on the Fas signal using HCV transgenic mice, which expressed core, E1, E2, and NS2 proteins, regulated by the Cre/loxP switching system. The transgene expression of HCV transgenic mice caused resistance to Fas antibody stimulated lethality. Apoptotic cell death in the liver of HCV protein expressing mice was significantly reduced compared with nonexpressing mice. Histopathological analysis and DNA fragmentation analysis revealed that the HCV proteins suppressed Fas-mediated apoptotic cell death. To identify the target pathway of HCV proteins, we characterized caspase activity. The activation of caspase-9 and -3/7 but not caspase-8 was inhibited by HCV proteins. Cytochrome c release from mitochondria was inhibited in HCV protein expressing mice. These results indicated that the expression of HCV proteins may directly or indirectly inhibit Fas-mediated apoptosis and death in mice by repressing the release of cytochrome c from mitochondria, thereby suppressing caspase-9 and -3/7 activation. These results suggest that HCV may cause persistent infection, as a result of suppression of Fas-mediated cell death.


Subject(s)
Cytochrome c Group/metabolism , Hepacivirus/metabolism , Signal Transduction/physiology , Viral Proteins/metabolism , fas Receptor/physiology , Animals , Apoptosis/physiology , Caspases/metabolism , Liver/metabolism , Mice , Mice, Inbred BALB C , Mice, Transgenic
3.
Cancer Lett ; 165(2): 155-9, 2001 Apr 26.
Article in English | MEDLINE | ID: mdl-11275364

ABSTRACT

A light-induced fluorescence endoscopy in the gastrointestinal tract system was used in 52 patients with 54 lesions (33 early gastric cancers, 21 benign lesions) to assess its ability to detect early gastric cancer. Comparing the images with the histological findings, 21 of the 33 carcinomas appeared dark red, ten had a mixed pattern of dark red and white, and two could not be detected. Of the 21 benign lesions, 18 appeared light blue, as do normal mucosa, with this system. In 85% of the cancer lesions (28/33), cancer extension was correctly detected. The sensitivity and specificity were 94 and 86%, respectively. Real-time autofluorescence endoscopy is a useful adjunct to conventional white-light endoscopy for detecting early gastric cancer.


Subject(s)
Carcinoma/diagnosis , Carcinoma/pathology , Gastroscopy/methods , Stomach Neoplasms/diagnosis , Stomach Neoplasms/pathology , Humans , Hyperplasia/diagnosis , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...